J Neurol Surg B Skull Base 2016; 77(01): 061-065
DOI: 10.1055/s-0035-1560047
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Plasmacytoma of the Skull Base: A Meta-Analysis

Shorook Na'ara
1   Department of Otolaryngology, Head and Neck Surgery, The Head and Neck Center, Rambam Medical Campus, Haifa, Israel
2   The Laboratory for Applied Cancer Research, CRIR, Rambam Medical Campus, Haifa, Israel
,
Moran Amit
1   Department of Otolaryngology, Head and Neck Surgery, The Head and Neck Center, Rambam Medical Campus, Haifa, Israel
2   The Laboratory for Applied Cancer Research, CRIR, Rambam Medical Campus, Haifa, Israel
,
Ziv Gil
1   Department of Otolaryngology, Head and Neck Surgery, The Head and Neck Center, Rambam Medical Campus, Haifa, Israel
2   The Laboratory for Applied Cancer Research, CRIR, Rambam Medical Campus, Haifa, Israel
,
Salem Billan
3   Oncology Department, Rambam Medical Campus, Haifa, Israel
› Author Affiliations
Further Information

Publication History

12 May 2015

25 June 2015

Publication Date:
20 August 2015 (online)

Abstract

Objective Extramedullary plasmacytomas are rare tumors. In the current study we aim to characterize its clinical course at the skull base and define the most appropriate therapeutic protocol.

Methods We conducted a meta-analysis of articles in the English language that included data on the treatment and outcome of plasmacytoma of the base of skull.

Results The study cohort consisted of 47 patients. The tumor originated from the clivus and sphenoclival region in 28 patients (59.5%), the nasopharynx in 10 patients (21.2%), the petrous apex in 5 patients (10.6%), and the orbital roof in 4 patients (8.5%). The chief complaints at presentation included recurrent epistaxis and cranial nerve palsy, according to the site of tumor. Twenty-two patients (46.8%) had surgical treatment; 25 (53.2%) received radiation therapy. Adjuvant therapy was administered in 11 cases (50%) with concurrent multiple myeloma.

The 2-year and 5-year overall survival rates were 78% and 59%, respectively. Clear margin resection was achieved in a similar proportion of patients who underwent endoscopic surgery and open surgery (p = 0.83). A multivariate analysis of outcome showed a similar survival rate of patients treated surgically or with radiotherapy.

Conclusions The mainstay of treatment for plasmacytoma is based on radiation therapy, but when total resection is feasible, endoscopic resection is a valid option.

 
  • References

  • 1 Corwin J, Lindberg RD. Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma. Cancer 1979; 43 (3) 1007-1013
  • 2 Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992; 69 (6) 1513-1517
  • 3 Bolek TW, Marcus Jr RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1996; 36 (2) 329-333
  • 4 Ceylan S, Koc K, Anik I. Extended endoscopic approaches for midline skull-base lesions. Neurosurg Rev 2009; 32 (3) 309-319 ; discussion 318–319
  • 5 Liu ZY, Qi XQ, Wu XJ, Luo C, Lu YC. Solitary intracranial plasmacytoma located in the spheno-clival region mimicking chordoma: a case report. J Int Med Res 2010; 38 (5) 1868-1875
  • 6 Kashyap R, Kumar R, Kumar S. Cranial nerve palsy in multiple myeloma and solitary plasmacytoma. Asia Pac J Clin Oncol 2010; 6 (4) 251-255
  • 7 Joshi A, Jiang D, Singh P, Moffat D. Skull base presentation of multiple myeloma. Ear Nose Throat J 2011; 90 (1) E6-E9
  • 8 Park SH, Kim YZ, Lee EH, Kim KH. Endoscopic endonasal transsphenoidal resection of solitary extramedullary plasmacytoma in the sphenoid sinus with destruction of skull base. J Korean Neurosurg Soc 2009; 46 (2) 156-160
  • 9 Husein OF, Jacob A, Massick DD, Welling DB. Recurrence of isolated multiple myeloma in the skull base: a case report and review of the literature. Ear Nose Throat J 2007; 86 (9) 555-560
  • 10 Wein RO, Popat SR, Doerr TD, Dutcher PO. Plasma cell tumors of the skull base: four case reports and literature review. Skull Base 2002; 12 (2) 77-86
  • 11 Wong ET, Lu XQ, Devulapalli J, Mahadevan A. Cyberknife radiosurgery for basal skull plasmacytoma. J Neuroimaging 2006; 16 (4) 361-363
  • 12 Ustuner Z, Basaran M, Kiris T , et al. Skull base plasmacytoma in a patient with light chain myeloma. Skull Base 2003; 13 (3) 167-171
  • 13 Hogan MC, Lee A, Solberg LA, Thomé SD. Unusual presentation of multiple myeloma with unilateral visual loss and numb chin syndrome in a young adult. Am J Hematol 2002; 70 (1) 55-59
  • 14 Movsas TZ, Balcer LJ, Eggenberger ER, Hess JL, Galetta SL. Sixth nerve palsy as a presenting sign of intracranial plasmacytoma and multiple myeloma. J Neuroophthalmol 2000; 20 (4) 242-245
  • 15 Meyer JR, Roychowdhury S, Cybulski G, Russell EJ. Solitary intramedullary plasmacytoma of the skull base mimicking aggressive meningioma. Skull Base Surg 1997; 7 (2) 101-105
  • 16 Bindal AK, Bindal RK, van Loveren H, Sawaya R. Management of intracranial plasmacytoma. J Neurosurg 1995; 83 (2) 218-221
  • 17 Nikolidakis AA, Skoulakis CE, Papadakis CE, Chryssou E, Bizakis JG, Helidonis ES. Solitary extramedullary plasmacytoma of the nasopharynx. J Otolaryngol 2000; 29 (4) 254-257
  • 18 Kingdom TT, Delgaudio JM. Endoscopic approach to lesions of the sphenoid sinus, orbital apex, and clivus. Am J Otolaryngol 2003; 24 (5) 317-322
  • 19 Kurtsoy A, Menku A, Tucer B, Suat Oktem I, Akdemir H, Kemal Koc R. Transbasal approaches: surgical details, pitfalls and avoidances. Neurosurg Rev 2004; 27 (4) 267-273
  • 20 CampisI P, Frenkiel S, Glikstein R, Mohr G. Unilateral sixth cranial nerve palsy caused by skull base mass lesions: case series. J Otolaryngol 2001; 30 (3) 184-186
  • 21 Cerase A, Tarantino A, Gozzetti A , et al. Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology 2008; 50 (8) 665-674
  • 22 Brannan SO, Matthews BN, Savant V, Brown RD, Matthews TD. Solitary intracranial extra-osseous plasmacytoma presenting with ophthalmic signs. J Neuroophthalmol 2003; 23 (4) 268-271
  • 23 Gagliardi F, Losa M, Boari N , et al. Solitary clival plasmocytomas: misleading clinical and radiological features of a rare pathology with a specific biological behaviour. Acta Neurochir (Wien) 2013; 155 (10) 1849-1856
  • 24 Guinto-Balanzar G, Abdo-Toro M, Aréchiga-Ramos N, Leal-Ortega R, Zepeda-Fernández E, Nambo-Lucio MdeJ. Plasma cell tumor of the clivus: report of two cases. Cir Cir 2012; 80 (2) 171-176
  • 25 Nofsinger YC, Mirza N, Rowan PT, Lanza D, Weinstein G. Head and neck manifestations of plasma cell neoplasms. Laryngoscope 1997; 107 (6) 741-746
  • 26 Sulzner SE, Amdur RJ, Weider DJ. Extramedullary plasmacytoma of the head and neck. Am J Otolaryngol 1998; 19 (3) 203-208
  • 27 Susnerwala SS, Shanks JH, Banerjee SS, Scarffe JH, Farrington WT, Slevin NJ. Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases. Br J Cancer 1997; 75 (6) 921-927
  • 28 Toland J, Phelps PD. Plasmacytoma of the skull base. Clin Radiol 1971; 22 (1) 93-96
  • 29 Wachter D, Böker DK, Huegens-Penzel M, Kuchelmeister K, Jödicke A. First manifestation of lambda positive plasmacytoma in the orbital apex with acute unilateral loss of vision. Minim Invasive Neurosurg 2010; 53 (2) 74-76
  • 30 Wax MK, Yun KJ, Omar RA. Extramedullary plasmacytomas of the head and neck. Otolaryngol Head Neck Surg 1993; 109 (5) 877-885
  • 31 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-1992. A 65-year-old man with a mass that involved the base of the skull. N Engl J Med 1992; 326 (21) 1417-1424
  • 32 Higurashi M, Yagishita S, Fujitsu K, Kitsuta Y, Takemoto Y, Osano S. Plasma cell myeloma of the skull base: report of two cases. Brain Tumor Pathol 2004; 21 (3) 135-141
  • 33 Wasserman TH. Diagnosis and management of plasmacytomas. Oncology (Williston Park) 1987; 1 (2) 37-41
  • 34 Mill WB, Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer 1980; 45 (4) 647-652